Professor, Psychiatry, Washington University School of Medicine
Psychiatry
Dr. Nuri B. Farber, MD
|
|
Give Review
Nuri B. Farber works in the field of Psychiatry. He graduated from Washington University School of Medicine in St. Louis. Nuri Farber is a published doctor and has 51 publications published. The lastest was: 'The glutamate synapse in neuropsychiatric disorders. Focus on schizophrenia and Alzheimer''s disease.' Nuri Farber accepts Medicare payments and is registered with Medicare.gov.
Publications
- Ninety-six hour ketamine infusion with co-administered clonidine for treatment-resistant depression: A pilot randomised controlled trial.
- Lithium protects against glucocorticoid induced neural progenitor cell apoptosis in the developing cerebellum.
- Ketamine-induced Neuroapoptosis in the Fetal and Neonatal Rhesus Macaque Brain.
- Glucocorticoid receptor stimulation and the regulation of neonatal cerebellar neural progenitor cell apoptosis.
- Alcohol-induced neuroapoptosis in the fetal macaque brain.
- Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain.
- Behavioral consequences of NMDA antagonist-induced neuroapoptosis in the infant mouse brain.
- Dimethyl sulfoxide (DMSO) produces widespread apoptosis in the developing central nervous system.
- Donepezil markedly potentiates memantine neurotoxicity in the adult rat brain.
- Acute D2/D3 dopaminergic agonism but chronic D2/D3 antagonism prevents NMDA antagonist neurotoxicity.
- Architecture and neurocytology of monkey cingulate gyrus.
- The NMDA receptor hypofunction model of Psychosis.
- Glutamate and GABA receptor dysfunction in the fetal Alcohol syndrome.
- High dose magnesium sulfate exposure induces apoptotic cell death in the developing neonatal mouse brain.
- Age has a similar influence on the susceptibility to NMDA antagonist-induced neurodegeneration in most brain regions.
- Drugs of abuse that cause developing neurons to commit suicide.
- In the adult CNS, ethanol prevents rather than produces NMDA antagonist-induced neurotoxicity.
- Muscimol prevents NMDA antagonist neurotoxicity by activating GABAA receptors in several brain regions.
- The enigma of fetal Alcohol neurotoxicity.
- Drug-induced apoptotic neurodegeneration in the developing brain.
- Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to Schizophrenia?
- Multifocal brain damage induced by phencyclidine is augmented by pilocarpine.
- Serotonergic agents that activate 5HT2A receptors prevent NMDA antagonist neurotoxicity.
- Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and Psychosis.
- Receptor mechanisms and circuitry underlying NMDA antagonist neurotoxicity.
- Acute neonatal glucocorticoid exposure produces selective and rapid cerebellar neural progenitor cell apoptotic death.
- Low-level lead exposure triggers neuronal apoptosis in the developing mouse brain.
- EnvironMental agents that have the potential to trigger massive apoptotic neurodegeneration in the developing brain.
- Antiepileptic Drugs and agents that inhibit voltage-gated sodium channels prevent NMDA antagonist neurotoxicity.
- Antipsychotic Drugs block phencyclidine receptor-mediated neurotoxicity.
- NMDA receptor hypofunction model of Schizophrenia.
- Chronic but not acute estradiol treatment protects against the neurodegenerative effects of N-methyl-D-aspartate receptor antagonists.
- NMDA antagonists as neurotherapeutic Drugs, psychotogens, neurotoxins, and research tools for studying schizophrenia.
- Glutamate receptor dysfunction and Schizophrenia.
- alpha 2 adrenergic agonists prevent MK-801 neurotoxicity.
- Glycine agonists: what can they teach us about Schizophrenia?
- Excitotoxic neurodegeneration in Alzheimer disease. New hypothesis and new therapeutic strategies.
- Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity.
- Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)801 (dizocilpine maleate): a light and electron microscop...
- Efficacy of clozapine compared with other antipsychotics in preventing NMDA-antagonist neurotoxicity.
- Discussion of Bogerts' temporolimbic system theory of paranoid Schizophrenia.
- Glumate receptor dysfunction and Alzheimer''s disease.
- The glutamate synapse in neuropsychiatric Disorders. Focus on schizophrenia and Alzheimer''s disease.
- NMDA receptor function, memory, and brain aging.
- Increasing brain tumor rates: is there a link to aspartame?
- Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and alpha2-adrenergic agonists.
- Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and Psychosis.
- Assaults by patients on psychiatric residents at three training sites.
- Neurons of the olfactory epithelium in adult rats contain vimentin.
- Alcohol-induced apoptosis of oligodendrocytes in the fetal macaque brain.
Schools
Washington University In St Louis School Of Medicine
Barnes Hospital Washington University
Procedures Preformed
- Electroconvulsive Therapy (ECT)
Conditions Treated
- Alcoholism (Alcohol Dependence)
- Antisocial Personality Disorder
- Anxiety
- Bipolar Disorder
- View All
Doctors Specialties
- Geriatric Psychiatry
- Psychiatry
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Anthem Blue Cross Blue Shield PPO
- Blue Card PPO
- Blue Cross Blue Shield of Illinois PPO
- Coventry Health Care of Missouri PPO
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- United Healthcare
Education
-
Washington University - Barnes-Jewish Hospital -
Washington University School of Medicine in St. Louis
Hospital
-
Barnes-Jewish Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1487672804 |
| Last Name Of The Provider | FARBER |
| First Name Of The Provider | NURI |
| View All |
Similar Doctors
|
|
Dr. Indrapal Singh, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Vadim Y. Baram, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph D. Behrmann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George T. Grossberg, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Brianne M. Disabato, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jahnavi R. Handa, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pratibha N. Gurusiddaiya, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark C. Johnson, MD |
|
|
Dr. Diane Rankin, MD |
|
|
Dr. Charles F. Zorumski, MD |
|
|
Dr. Susan K. Boyer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Arshad Bhatt, MD |
|
|
Dr. Keith E. Isenberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Praveen S. Nimmagadda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William A. Kelly, MD |
|
|
Dr. Sanjeev M. Kamat, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William M. Redden, MD |
|
|
Dr. Srinivasa Donthi Reddy, MD |
|
|
Dr. Sudha M. Patel, MD |
|
|
Dr. Kevin J. Black, MD |
|
|
Dr. Kalu I. Onuma, MD
This Doctor is OpenDoctor Recommended.
|